Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

Joachim Baech*, Marianne Tang Severinsen, Andreas Kiesbye Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Meszaros Jørgensen, Michael Roost Clausen, Christian Bjørn Poulsen, Peter Brown, Anne Ortved Gang, Robert Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec C El Galaly

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Downloads (Pure)
Original languageEnglish
JournalBlood advances
Volume6
Issue number15
Pages (from-to)4427-4435
Number of pages9
ISSN2473-9529
DOIs
Publication statusPublished - 9 Aug 2022

Bibliographical note

© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Keywords

  • Cardiovascular Diseases/etiology
  • Cohort Studies
  • Diabetes Mellitus/drug therapy
  • Humans
  • Insulins/therapeutic use
  • Lymphoma, Non-Hodgkin/complications
  • Prednisone/adverse effects

Fingerprint

Dive into the research topics of 'Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy'. Together they form a unique fingerprint.

Cite this